Reports
China Diabetes Market Size, Share, Trends, Growth, Forecast: By Segment: China Oral Antidiabetics Market, China Insulin Market; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Competitive Landscape; 2024-2032
China Diabetes Market Outlook
The China diabetes market size reached a value of almost USD 4.32 billion in the year 2023. The market is further expected to grow at a CAGR of 9.5% between 2024 and 2032 to reach a value of almost USD 7.43 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The China diabetes market is driven by numerous healthcare reforms. Currently, the country represents one of the largest diabetic populations across the globe. China has about 11% of the global adult diabetic population (according to the International Diabetes Federation), due to the increase of more than nine-fold increase in cases within a generation. This can be attributed to the unhealthy eating patterns, hectic lifestyle, significant economic growth, and lack of physical activity, accelerating the population of overweight and obese people in the country.
Properties and Applications
Diabetes is referred to as a chronic disease that adversely impacts the body's ability to generate adequate insulin, break down the sugar present in food, or use insulin efficiently. It can lead to premature death or severe complications, such as amputation, stroke, and kidney and heart diseases. Diabetes is mainly categorized into three types, such as type 1, type 2, and gestational diabetes.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The China diabetes market is bifurcated on the basis of segment into:
- China Oral Antidiabetics Market
- China Insulin Market
Currently, insulin holds the majority of the total market share due to the increasing number of production facilities across China. The manufacturers produce and supply insulin pumps, along with other insulin delivery systems throughout the country.
The major regional markets for the product include Shanghai, Zhejiang, Guangdong, Jiangsu, and Beijing, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The China diabetes market is driven by the higher vulnerability of Chinese people to diabetes as compared to Europeans. The industry is further aided by the unawareness regarding health issues, considerable consumption of white rice, and poor healthcare infrastructure in the country, which represent some of the major significant factors driving the incidences of diabetes. Thus, the Chinese government is introducing several healthcare reforms, which is invigorating the diabetes industry growth. For instance, it is encouraging foreign investments and permitting multinational companies (MNCs) to extend their services within China. This has helped patients to diagnose diabetes at the early stage and manage it properly. Also, several drug manufacturers in China are focusing on expanding their budget for research and development (R&D) activities in the industry to develop innovative drugs. This trend, along with the highly developed pharmaceutical industry within China, is contributing to the industry growth in the country.
Competitive Landscape
The report gives a detailed analysis of the following key players in the China diabetes market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Abbott
- Medtronic
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Segment, Region |
| Breakup by Segment | China Oral Antidiabetics Market, China Insulin Market |
| Breakup by Region | Shanghai, Zhejiang, Guangdong, Jiangsu, Beijing, Others |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Abbott, Medtronic, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 China
6.2 Regional
7 Opportunities and Challenges in the Market
8 China Diabetes Epidemiology
8.1 Diabetes Population and Prevalence Rates
8.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
8.3 Population and Prevalence Rates by Region
8.4 Population and Prevalence Rates by Age Group
9 China Diabetes Market Analysis
9.1 Key Industry Highlights
9.2 China Diabetes Historical Market (2018-2023)
9.3 China Diabetes Market Forecast (2024-2032)
9.4 China Diabetes Market by Segment
9.4.1 China Oral Antidiabetics Market
9.4.1.1 Historical Trend (2018-2023)
9.4.1.2 Forecast Trend (2024-2032)
9.4.1.3 Market by Class
9.4.1.4 Market Share by Key Players
9.4.2 China Insulin Market
9.4.2.1 Historical Trend (2018-2023)
9.4.2.2 Forecast Trend (2024-2032)
9.4.2.3 Market by Class
9.4.2.4 Market Share by Key Players
9.5 China Diabetes Market by Region
9.5.1 Shanghai
9.5.2 Zhejiang
9.5.3 Guangdong
9.5.4 Jiangsu
9.5.5 Beijing
9.5.6 Others
10 Regional Analysis
10.1 Shanghai
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Zhejiang
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 Guangdong
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Jiangsu
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Beijing
10.5.1 Historical Trend (2018-2023)
10.5.2 Forecast Trend (2024-2032)
11 Market Dynamics
11.1 SWOT Analysis
11.1.1 Strengths
11.1.2 Weaknesses
11.1.3 Opportunities
11.1.4 Threats
11.2 Porter’s Five Forces Analysis
11.2.1 Supplier’s Power
11.2.2 Buyers Power
11.2.3 Threat of New Entrants
11.2.4 Degree of Rivalry
11.2.5 Threat of Substitutes
11.3 Key Indicators for Demand
11.4 Key Indicators for Price
12 Value Chain Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Company Profiles (*This list is only indicative. The report contains a more comprehensive list of players.)
13.2.1 Abbott
13.2.1.1 Company Overview
13.2.1.2 Demographic Reach and Achievements
13.2.1.3 Certifications
13.2.2 Medtronic
13.2.2.1 Company Overview
13.2.2.2 Demographic Reach and Achievements
13.2.2.3 Certifications
13.2.3 Others
14 Key Trends and Developments in the Market
List of Key Figures and Tables
1. China Diabetes Market: Key Industry Highlights, 2018 and 2032
2. China Diabetes Epidemiology: Diabetes Population and Prevalence Rates
3. China Diabetes Epidemiology: Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
4. China Diabetes Epidemiology: Population and Prevalence Rates by Region
5. China Diabetes Epidemiology: Population and Prevalence Rates by Gender
6. China Diabetes Epidemiology: Population and Prevalence Rates by Age Group
7. China Diabetes Historical Market: Breakup by Segment (USD Billion), 2018-2023
8. China Diabetes Market Forecast: Breakup by Segment (USD Billion), 2024-2032
9. China Diabetes Historical Market: Breakup by Region (USD Billion), 2018-2023
10. China Diabetes Market Forecast: Breakup by Region (USD Billion), 2024-2032
11. China Diabetes Market Structure
Key Questions Answered in the Report
In 2023, the China diabetes market attained a value of nearly USD 4.32 billion.
The market is projected to grow at a CAGR of 9.5% between 2024 and 2032.
The market is estimated to grow in the forecast period of 2024-2032 to reach about USD 7.43 billion by 2032.
The major market drivers are unhealthy eating patterns and hectic lifestyles of the working population, the growing obese population, the significant consumption of white rice, and the introduction of various healthcare reforms by the Chinese government.
The key trends guiding the market include increasing investments in research and development (R&D) activities by the government and private organisations to develop new drugs and growing technological advancements.
The major regions in the market are Shanghai, Zhejiang, Guangdong, Jiangsu, and Beijing.
China oral antidiabetics and China insulin market are the major segments considered in the market report.
The major players in the market are Abbott, and Medtronic, among others.
Analyst Review
The China diabetes market attained a value of USD 4.32 billion in 2022 driven by the considerable consumption of white rice and the implementation of favourable government policies to develop the healthcare sector in the region. Aided by increased funding towards research and development (R&D) activities and development of new drugs, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 9.5%. The industry is projected to reach USD 7.43 billion by 2032.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its segment, the diabetes industry in China can be bifurcated into antidiabetics and insulin markets, with the insulin segment accounting for the largest market share. The major regional markets for diabetes in China are Shanghai, Zhejiang, Guangdong, Jiangsu, and Beijing. The key players in the above market include Abbott, and Medtronic, among others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with industry insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER